Annual CFI
-$153.00 K
+$213.00 K+58.20%
December 31, 2023
Summary
- As of February 8, 2025, ATNM annual cash flow from investing activities is -$153.00 thousand, with the most recent change of +$213.00 thousand (+58.20%) on December 31, 2023.
- During the last 3 years, ATNM annual CFI has risen by +$100.00 thousand (+39.53%).
Performance
ATNM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, ATNM quarterly cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, ATNM quarterly CFI has stayed the same.
- ATNM quarterly CFI is now -100.00% below its all-time high of $25.00 thousand, reached on December 31, 2011.
Performance
ATNM Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$11.00 K
+$30.00 K+73.17%
September 30, 2024
Summary
- As of February 8, 2025, ATNM TTM cash flow from investing activities is -$11.00 thousand, with the most recent change of +$30.00 thousand (+73.17%) on September 30, 2024.
- Over the past year, ATNM TTM CFI has increased by +$142.00 thousand (+92.81%).
- ATNM TTM CFI is now -146.22% below its all-time high of $23.80 thousand, reached on June 30, 2012.
Performance
ATNM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ATNM Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +58.2% | 0.0% | +92.8% |
3 y3 years | +39.5% | +100.0% | +97.1% |
5 y5 years | -59.2% | 0.0% | +82.8% |
ATNM Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -15.0% | +58.2% | at high | +100.0% | at high | +97.5% |
5 y | 5-year | -139.1% | +58.2% | at high | +100.0% | -120.0% | +97.5% |
alltime | all time | <-9999.0% | +58.2% | -100.0% | +100.0% | -146.2% | +97.5% |
Actinium Pharmaceuticals Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $0.00(0.0%) | -$11.00 K(-73.2%) |
Jun 2024 | - | $0.00(-100.0%) | -$41.00 K(-53.4%) |
Mar 2024 | - | -$11.00 K(<-9900.0%) | -$88.00 K(-42.5%) |
Dec 2023 | -$153.00 K(-58.2%) | $0.00(-100.0%) | -$153.00 K(-9.5%) |
Sep 2023 | - | -$30.00 K(-36.2%) | -$169.00 K(-20.3%) |
Jun 2023 | - | -$47.00 K(-38.2%) | -$212.00 K(-51.3%) |
Mar 2023 | - | -$76.00 K(+375.0%) | -$435.00 K(+18.9%) |
Dec 2022 | -$366.00 K(+175.2%) | -$16.00 K(-78.1%) | -$366.00 K(+4.6%) |
Sep 2022 | - | -$73.00 K(-73.0%) | -$350.00 K(+1.4%) |
Jun 2022 | - | -$270.00 K(+3757.1%) | -$345.00 K(+153.7%) |
Mar 2022 | - | -$7000.00(<-9900.0%) | -$136.00 K(+2.3%) |
Dec 2021 | -$133.00 K(-47.4%) | $0.00(-100.0%) | -$133.00 K(-64.8%) |
Sep 2021 | - | -$68.00 K(+11.5%) | -$378.00 K(+18.9%) |
Jun 2021 | - | -$61.00 K(+1425.0%) | -$318.00 K(+23.7%) |
Mar 2021 | - | -$4000.00(-98.4%) | -$257.00 K(+1.6%) |
Dec 2020 | -$253.00 K(+295.3%) | -$245.00 K(+2962.5%) | -$253.00 K(+1846.2%) |
Sep 2020 | - | -$8000.00(<-9900.0%) | -$13.00 K(+160.0%) |
Jun 2020 | - | $0.00(0.0%) | -$5000.00(-61.5%) |
Mar 2020 | - | $0.00(-100.0%) | -$13.00 K(-79.7%) |
Dec 2019 | -$64.00 K(-33.4%) | -$5000.00(<-9900.0%) | -$64.00 K(-8.0%) |
Sep 2019 | - | $0.00(-100.0%) | -$69.60 K(-45.8%) |
Jun 2019 | - | -$8000.00(-84.3%) | -$128.30 K(-8.4%) |
Mar 2019 | - | -$51.00 K(+381.1%) | -$140.10 K(+45.8%) |
Dec 2018 | -$96.10 K(+289.1%) | -$10.60 K(-81.9%) | -$96.10 K(+10.7%) |
Sep 2018 | - | -$58.70 K(+196.5%) | -$86.80 K(+148.7%) |
Jun 2018 | - | -$19.80 K(+182.9%) | -$34.90 K(+48.5%) |
Mar 2018 | - | -$7000.00(+438.5%) | -$23.50 K(-5.2%) |
Dec 2017 | -$24.70 K(-77.5%) | -$1300.00(-80.9%) | -$24.80 K(-39.1%) |
Sep 2017 | - | -$6800.00(-19.0%) | -$40.70 K(+15.6%) |
Jun 2017 | - | -$8400.00(+1.2%) | -$35.20 K(-13.5%) |
Mar 2017 | - | -$8300.00(-51.7%) | -$40.70 K(-62.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2016 | -$109.80 K(+129.7%) | -$17.20 K(+1223.1%) | -$109.80 K(-3.2%) |
Sep 2016 | - | -$1300.00(-90.6%) | -$113.40 K(-17.9%) |
Jun 2016 | - | -$13.90 K(-82.0%) | -$138.10 K(+10.3%) |
Mar 2016 | - | -$77.40 K(+272.1%) | -$125.20 K(+161.9%) |
Dec 2015 | -$47.80 K(-74.4%) | -$20.80 K(-20.0%) | -$47.80 K(-23.5%) |
Sep 2015 | - | -$26.00 K(+2500.0%) | -$62.50 K(+6.1%) |
Jun 2015 | - | -$1000.00(<-9900.0%) | -$58.90 K(-68.1%) |
Mar 2015 | - | $0.00(-100.0%) | -$184.60 K(-0.9%) |
Dec 2014 | -$186.40 K(+1022.9%) | -$35.50 K(+58.5%) | -$186.30 K(+16.9%) |
Sep 2014 | - | -$22.40 K(-82.3%) | -$159.40 K(+10.8%) |
Jun 2014 | - | -$126.70 K(+7352.9%) | -$143.90 K(+736.6%) |
Mar 2014 | - | -$1700.00(-80.2%) | -$17.20 K(+3.6%) |
Dec 2013 | -$16.60 K(+591.7%) | -$8600.00(+24.6%) | -$16.60 K(+95.3%) |
Sep 2013 | - | -$6900.00(<-9900.0%) | -$8500.00(+269.6%) |
Jun 2013 | - | $0.00(-100.0%) | -$2300.00(0.0%) |
Mar 2013 | - | -$1100.00(+120.0%) | -$2300.00(-4.2%) |
Dec 2012 | -$2400.00(<-9900.0%) | -$500.00(-28.6%) | -$2400.00(-110.4%) |
Sep 2012 | - | -$700.00(<-9900.0%) | $23.10 K(-2.9%) |
Jun 2012 | - | $0.00(-100.0%) | $23.80 K(-2083.3%) |
Mar 2012 | - | -$1200.00(-104.8%) | -$1200.00(<-9900.0%) |
Dec 2011 | $0.00(0.0%) | $25.00 K(>+9900.0%) | $0.00(-100.0%) |
Sep 2011 | - | $0.00(-100.0%) | -$25.00 K(0.0%) |
Jun 2011 | - | -$25.00 K(<-9900.0%) | -$25.00 K(<-9900.0%) |
Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2010 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sep 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2008 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2008 | - | $0.00 | $0.00 |
FAQ
- What is Actinium Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals annual CFI year-on-year change?
- What is Actinium Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly CFI year-on-year change?
- What is Actinium Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals TTM CFI year-on-year change?
What is Actinium Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ATNM is -$153.00 K
What is the all time high annual CFI for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high annual cash flow from investing activities is $0.00
What is Actinium Pharmaceuticals annual CFI year-on-year change?
Over the past year, ATNM annual cash flow from investing activities has changed by +$213.00 K (+58.20%)
What is Actinium Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ATNM is $0.00
What is the all time high quarterly CFI for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high quarterly cash flow from investing activities is $25.00 K
What is Actinium Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, ATNM quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Actinium Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ATNM is -$11.00 K
What is the all time high TTM CFI for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high TTM cash flow from investing activities is $23.80 K
What is Actinium Pharmaceuticals TTM CFI year-on-year change?
Over the past year, ATNM TTM cash flow from investing activities has changed by +$142.00 K (+92.81%)